iSpecimen Reports Full Year 2021 Financial Results
Record FY 2021 Revenue of $11.1 Million, Surpassing FY 2020 Revenue of $8.2 Million by 36%LEXINGTON, Mass., Feb. 17, 2022...
Staff
Intellia Therapeutics Announces Two Upcoming Investor Events in February 2022
Fourth quarter and full-year 2021 financial results – February 24, at 8:00 a.m. ETUpdated interim clinical data from the ongoing...
Arbutus to Report Fourth Quarter and Year End 2021 Financial Results and Provide Corporate Update
WARMINSTER, Pa., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive...
Kura Oncology to Report Fourth Quarter and Full Year 2021 Financial Results
SAN DIEGO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing...
Otonomy to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update
SAN DIEGO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative...
Avalo Therapeutics Announces Leadership Transition
Promotes Dr. Garry Neil to Chief Executive OfficerPromotes Chris Sullivan to Chief Financial Officer WAYNE, Pa. and ROCKVILLE, Md., Feb....
XOMA to Present at Aegis Capital Corp Investor Conference
EMERYVILLE, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role...
Repligen Reports Fourth Quarter and Full Year 2021 Financial Results
— Record revenue of $186.5 million for the quarter, and year-over-year growth of 72% — Record revenue of $670.5 million...
Ultimovacs ASA: Mandatory notification of trade by primary insider
Oslo, 17 February 2022, Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 1,000...
Resverlogix Expands Phase 2b Clinical Trial for COVID-19 Treatment with First Site in Brazil and Second in Canada
CALGARY, Alberta, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced that the first Brazilian site has...
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with InterVivo Solutions
TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
Evelo Biosciences Announces Dosing of First Patient in Phase 2 Trial of EDP1815 in Atopic Dermatitis
CAMBRIDGE, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing SINTAX™ medicines...
Microbix Presenting at Capital Conference in B.C.
Meetings with Growth-Oriented Investors, February 18-20, 2022MISSISSAUGA, Ontario, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Tilray Launches Medical Cannabis Products in Malta
LEAMINGTON, Ontario, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a...
R1 RCM Reports Fourth Quarter and Full Year 2021 Results
MURRAY, Utah, Feb. 17, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that...
Syneos Health Reports Fourth Quarter and Full Year 2021 Results
Highlights Fourth quarter revenue of $1,373.4 million increased 20.5% year-over-year.Clinical Solutions net new business awards and book-to-bill ratios: Including reimbursable...
Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Like Molecules
Entactogen NCE Series Enhances the Potential to Treat a Broad Range of AddictionsToronto, Ontario--(Newsfile Corp. - February 17, 2022) -...
Verato and Particle Health Partner to Improve Interoperability and Data Efficacy for Healthcare and Technology Solutions
The Verato Universal MPI integrates with Particle Health’s intuitive API platform to improve data matching and aggregation across the care...
MEDITECH Brings Transformation in Motion to HIMSS22
Visit MEDITECH at booth #3311 and hear from clinician experts about how Expanse improves mobility, usability, and efficiency for their...
Emids Launches Extensive Rebranding Initiative
Company’s revitalized identity and core values capture its vision of human-centered healthcare innovation NASHVILLE, Tenn.--(BUSINESS WIRE)--Emids, the proven leader in...